🔗 Share this article

An underground market for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Investigational Treatment Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these profiles privately for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where groups with numerous of members share “before and after” photos, injection guides and claims of rapid British shipping. Vendors promote the drug there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, physicians and chemists have warned that the sale of what remains an unapproved drug in the UK is worrisome and could lead to users administering products of unknown origin.

Some experts stated the demand for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and customer laws, risking fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to the social media company, the platform has taken down problematic content and prohibited related hashtags and query recommendations. The organization said it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Trading Activities

Research also found groups with up to 9,000 members marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, filled with photos of weight loss, positive reviews and step-by-step instructions for mixing or injecting at residence.

Within minutes of joining one community, a seller shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about body mass, medical conditions or past usage.

Product Information and Costs

Inside these communities, messages display black plastic parcels with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When asked how much time a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they can’t verify. Even if the science behind retatrutide is valid, these digital versions may not include what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in interest to current price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has previously encountered individuals injured by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may subject users to potentially serious medical dangers”.